Thinking About Orencia, Read This First…

by Support on April 3, 2011

If you have been considering using Orencia, have been recommended to use it or are currently on a prescription for Orencia then you should read this excerpt from a Reuters Report. As always you can link to the full article below.

UK’s Cost Agency Rebuffs Bristol Arthritis Drug

LONDON (Reuters) – Britain’s healthcare cost watchdog NICE has recommended against using Bristol-Myers Squibb’s rheumatoid arthritis drug Orencia on the state health service as a second-line treatment.

The National Institute for Health and Clinical Excellence (NICE) said on Wednesday it did not support giving the biotech drug to rheumatoid arthritis patients whose disease has not responded adequately to conventional non-biological medicines.

NICE already recommends four other biotech drugs for such second-line use.

NICE’s decisions are often watched by governments around the world who increasingly have to weigh the benefits of modern medicines against their price. Orencia costs around 10,000 pounds ($16,000) per patient a year.

View the original article here

Victorian Arthritis Sufferers, Internet To The Rescue

Leave a Comment

Spam Protection by WP-SpamFree

Previous post: Rheumatoid Arthritis Natural Home Remedies

Next post: Victorian Arthritis Sufferers, Internet to the Rescue